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1820Objective: To determine whether off-pump coronary artery bypass grafting (CABG) is associated with worse
long-term survival compared with on-pump CABG. We performed a meta-analysis of adjusted observational
studies and randomized controlled trials.
Methods:MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched through
March 2014. Eligible studies were randomized controlled trials and adjusted observational studies (in which
appropriate statistical methods adjusting for confounders had been used) of off-pump versus on-pump CABG
that had reported long-term (5-year) all-cause mortality as an outcome.
Results: Of 478 potentially relevant studies screened initially, 5 randomized trials and 17 observational studies,
enrolling a total of 104,306 patients, were identified and included. A pooled analysis of all 22 studies
demonstrated a statistically significant 7% increase in long-term all-cause mortality with off-pump relative
to on-pump CABG (hazard ratio, 1.07; 95% confidence interval, 1.03-1.11; P ¼ .0003). Although a pooled
analysis of 5 randomized trials (1486 patients) demonstrated a statistically nonsignificant 14% increase in
mortality with off-pump relative to on-pump CABG (hazard ratio, 1.14; 95% confidence interval, 0.84-1.56;
P ¼ .39), another pooled analysis of 17 observational studies (102,820 patients) demonstrated a statistically
significant 7% increase in mortality with off-pump relative to on-pump CABG (hazard ratio, 1.07; 95%
confidence interval, 1.03-1.11; P ¼ .0004).
Conclusions: A meta-analysis of 22 studies, enrolling a total of>100,000 patients, showed that off-pump
CABG is likely associated with worse long-term (5-year) survival compared with on-pump CABG. (J Thorac
Cardiovasc Surg 2014;148:1820-9)See related commentary on pages 1829-31.Supplemental material is available online.
ACochrane systematic review1 published in 2012 of 30 ran-
domized clinical trials did not demonstrate any significant
benefit for off-pump compared with on-pump coronary
artery bypass grafting (CABG) regarding mortality,
stroke, or myocardial infarction. In contrast, Møller and
colleagues1 observed, in a pooled analysis of 17 trials,2-18
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The Journal of Thoracic and Cardiovascular Surundergoing on-pump CABG with cardiopulmonary
bypass and cardioplegic arrest. The follow-up duration
of the included trials, however, was <3 years in 12
trials,3-6,8-14,17 3 but<5 years in 3 trials,7,16,18 and 5
years in only 2 trials.2,15 The results of our previous 2012
meta-analysis19 of 14 randomized controlled tri-
als2,4,6,8,9,14,15,17,18,20-24 suggested that off-pump CABG
might increase late (1-year) all-cause mortality by 35%
compared with on-pump CABG. The follow-up duration
of the included trials was<3 years in 8 trials,4,6,8,9,14,17,22,23
3 but <5 years in 1 trial,18 and 5 years in 5
trials.2,15,20,21,24 To determine whether off-pump CABG is
associated with worse long-term (5-year) survival
compared with on-pump CABG, we performed a meta-
analysis of adjusted observational studies (in which
appropriate statistical methods adjusting for confounders
had been used) and randomized controlled trials.METHODS
Search Strategy
All prospective randomized controlled trials and adjusted observational
comparative studies of off-pump versus on-pump CABG that had reported
long-term (5-year) all-cause mortality were identified using a 2-level
search strategy. First, databases, including MEDLINE, EMBASE, and the
Cochrane Central Register of Controlled Trials, were searched through
March 2014 using Web-based search engines (PubMed and OVID).gery c November 2014
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secondary sources, including the references of the initially identified studies,
and a search of reviews and commentaries. All references were downloaded
for consolidation, elimination of duplicates, and additional analysis. The text
keywords included ‘‘off-pump’’; ‘‘long-term’’ or ‘‘late’’; and ‘‘mortality,’’
‘‘death,’’ ‘‘deaths,’’ ‘‘survival,’’ ‘‘outcome,’’ ‘‘outcomes,’’ or ‘‘follow-up.’’
Study Selection and Data Abstraction
Studies considered for inclusion had to meet the following criteria: the
design was a prospective randomized controlled clinical trial or prospective
or retrospective adjusted observational comparative study (in which
appropriate statistical methods adjusting for confounders had been used);
the study population was patients undergoing CABG; the patients had
been assigned to off-pump versus on-pump CABG; and the main outcomes
included long-term all-cause mortality. We defined long-term mortality as
death during5 years of follow-up in the present analysis. When duplicate
reports from the same study were identified, only the most recent publica-
tion, or the one with the longest follow-up period, was included. Data
regarding detailed inclusion criteria, duration of follow-up, and mortality
were abstracted (as available) from each individual study. We extracted a
crude (unadjusted) hazard ratio (HR) and 95% confidence interval (CI)
of off-pump versus on-pump CABG for mortality from a randomized trial
and an adjusted HR (using appropriate statistical methods such as
propensity-score [PS] matching, PS stratification, PS-adjusted Cox propor-
tional hazards regression, multivariable Cox proportional hazards regres-
sion, and multivariable Poisson regression) from an observational study.
When the HR was unavailable from a randomized trial or PS-matched
study, the number of deaths in both the off-pump and on-pump groups
was used to generate the odds ratio and 95% CI instead of the HR.
Statistical Analysis
We conducted a meta-analysis of the summary statistics from the
individual studies. Study-specific estimates were combined using inverse
variance-weighted averages of logarithmic HRs in both fixed-effects and
random-effects models. Between-study heterogeneity was analyzed using
the standardchi-square test. If nosignificant statisticalheterogeneitywas iden-
tified, the fixed-effect estimate was used preferentially as the summary mea-
sure. Sensitivity analyses were performed to assess the contribution of each
study to the pooled estimate by excluding individual studies one at a time
and recalculating the pooledHRestimates for the remaining studies. To assess
the effect of differential adjustment methods among the observational studies
on the pooled estimate, the effects of off-pump CABG on mortality were
explored separately in the PS-matched studies. Publication bias was assessed
graphically using a funnel plot andmathematically using an adjusted rank cor-
relation and linear regression test. All analyses were conducted using Review
Manager, version 5.2 (Nordic Cochrane Centre, Copenhagen, Denmark), and
Comprehensive Meta-Analysis, version 2 (Biostat, Englewood, NJ).RESULTS
Search Results
Of 478 potentially relevant studies screened initially, 5
prospective randomized controlled clinical trials2,15,20,21,24The Journal of Thoracic and Carand 17 prospective or retrospective adjusted observational
comparative studiesE1-E17 of off-pump versus on-pump
CABG reporting long-term (5-year) all-cause mortality
were identified and included. In total, our meta-analysis
included data on 104,306 patients assigned to off-pump or
on-pump CABG. The study design and patient characteris-
tics are summarized in Table 1, details of revascularization
in Table 2, and graft patency and cardiac events in Table 3.
The number of grafts (or distal anastomoses) per patient
was reported in 16 studies and was significantly greater
for on-pump than off-pump CABG in 8 of the 16 studies
(Table 2). The completeness of revascularization was
provided in 8 studies, and the index of the completeness
of revascularization (or the frequency of complete
revascularization) was reported to be significantly greater
with on-pump than with off-pump CABG in 6 of the 8
studies (Table 2). In only 1 PS-matched study by Hu
and colleagues,E9 was repeat revascularization, angina,
and rehospitalization for cardiac reasons significantly
more frequent with off-pump than with on-pump CABG
(Table 3).
Primary Meta-Analysis
A pooled analysis of all 22 studies (104,306 patients)
demonstrated a statistically significant 7% increase in
long-term (5-year) all-cause mortality with off-pump
relative to on-pump CABG in the fixed-effects model
(HR, 1.07; 95% CI, 1.03-1.11; P for overall
effect ¼ .0003; Figure 1). Minimal trial heterogeneity
(P for heterogeneity ¼ .09) was present and, accordingly,
little difference in the pooled result from random-effects
modeling (HR, 1.06; 95% CI, 1.01-1.12; P for overall
effect ¼ .03). Although a pooled analysis of 5 randomized
controlled trials (1486 patients) demonstrated a statistically
nonsignificant 14% increase in mortality with off-pump
relative to on-pump CABG (fixed-effects HR, 1.14; 95%
CI, 0.84-1.56; P for overall effect ¼ .39; P for
heterogeneity ¼ .38), another pooled analysis of 17
adjusted observational studies (102,820 patients)
demonstrated a statistically significant 7% increase in
mortality with off-pump relative to on-pump CABG
(fixed-effects HR, 1.07; 95% CI, 1.03 to 1.11; P for overall
effect ¼ .0004; P for heterogeneity ¼ .06; Figure 1).
Sensitivity Analyses
To assess the effect of qualitative heterogeneity in study
design and patient selection on the pooled-effect estimate,
we performed several sensitivity analyses. First, we
excluded the highest weight (43.0%) and largest size
(35,644 patients) study by Bakaeen and colleaguesE2
(Continuous Improvement in Cardiac Surgery Program).
However, combining the remaining studies still generated
statistically significant results favoring on-pump CABG
(fixed-effects HR, 1.07; 95% CI, 1.02-1.13; P for overalldiovascular Surgery c Volume 148, Number 5 1821
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Deffect ¼ .003; P for heterogeneity ¼ .07). Second, we
sequentially excluded the second highest weight (12.0%)
study by Wu and colleaguesE12 (New York State’s Cardiac
Surgery Reporting System) and the second largest size
(12,874 patients) study by Cooper and colleagues.E3
Without the New York State’s Cardiac Surgery ReportingTABLE 1. Trial design and patient characteristics
Study
Name Duration Inclusion cri
Randomized controlled trial
Angelini (BHACAS
1 and 2),20 2009
March 1997 to August 1998,
BHACAS 1; September 1998
to November 1999, BHACAS 2
Recent MI (<1 mo) a
pronounced diseas
branches of circum
excluded in BHAC
not BHACAS 2*
Karolak,21 2007 August 1999 to March 2003 EF  30%; nonemerg
primary isolated C
Hueb (MASS III),15 2010 — Primary isolated CAB
van Dijk (Octopus),2 2007 1998-2000 Primary isolated CAB
Puskas (SMART),24 2011 March 2000 to August 2001 Elective primary isola
for multivessel dis
Adjusted observational study
Brown,E1 2008 January 2000 to June 2004 Nonemergency isolate
Bakaeen (CICSP),E2 2013 October 1997 to April 2011 Primary isolated CAB
Cooper,E3 2009 January 1997 to March 2007 Primary isolated CAB
Di Mauro,E4 2007 November 1994 to December 2001 Isolated CABG for m
disease
Filardo,E5 2011 1997-2008 Isolated CABG
Fu,E6 2009 1999-2005 Isolated CABG
Garcıa Fuster,E7 2013 January 1995 to June 2011 Elective primary isola
Gorki,E8 2010 January 1999 to September 2008 EF  30%; isolated c
disease
Hu,E9 2010 1999-2006 Isolated CABG
Locker,E10 2013 1993-2009 Primary isolated CAB
multivessel disease
Murzi,E11 2012 April 1996 to December 2009 Isolated CABG for le
disease
Wu (NY CSRS),E12 2012 July-December 2000 Isolated CABG
Raja,E13 2013 January-December 2002 Isolated CABG for m
disease
Robertson,E14 2013 January 1997 to June 2003 Primary isolated CAB
Sarin,E15 2011 January 1996 to September 2008 Isolated CABG
Dalen (SWEDEHEART),E16
2013
1998-2008 CABG in Sweden
Synnergren,E17 2008 1995-2004 Isolated CABG
DM, Diabetes mellitus; BHACAS, Beating Heart Against Cardioplegic Arrest Studies; MI,
IQR, interquartile range; MASS, Medicine, Angioplasty, or Surgery Study; SMART, Surgi
hazards regression; CICSP, Continuous Improvement in Cardiac Surgery Program; PS, pr
SWEDEHEART, Swedish Web-system for Enhancement and Development of Evidence-ba
patient-years. *Data from Angelini et al.3
1822 The Journal of Thoracic and Cardiovascular SurSystemE12 (fixed-effects HR, 1.06; 95% CI, 1.02 to 1.11;
P for overall effect ¼ .001; P for heterogeneity ¼ .08) or
the study by Cooper and colleaguesE3 (fixed-effects HR,
1.07; 95% CI, 1.03 to 1.11; P for overall effect ¼ .0006;
P for heterogeneity ¼ .07), the benefit for on-pump
CABG in the pooled analysis of the remaining studiesteria Adjustment Follow-up Subgroup
nd
e of distal
flex artery
AS 1 but
— 75.5  20.6 mo, off-pump;
76.7  19.3 mo, on-pump
BHACAS 1*
BHACAS 2*
Total*
ency
ABG
— 5 y (mean, 3.8; IQR, 3.4-4.4) —
G — 5 y —
G — 5 y —
ted CABG
ease
— Mean, 7.5 y (range, 6.8-8.4) —
d CABG Multivariable CPHR 6 y (median, 4.1) —
G PS matching Median, 6.68 y (IQR, 3.72-9.35) —
G PS-adjusted CPHR 10 y White
Black
Total
ultivessel PS matching 7.5  1.9 y —
PS-adjusted CPHR 10 y —
PS-adjusted CPHR 57.96  23.46 mo Men
Women
Total
ted CABG PS matching 77  53 mo, off-pump;
126  54 mo, on-pump
—
oronary PS matching 10 y (median, 44 mo; range,
0-120, off-pump; median,
64.8 mo; range, 0-120,
on-pump)
—
PS matching 8 y (mean, 4.5) —
G for Multivariable CPHR 7.6  4.6 y —
ft main PS matching 10 y (50.5  31.2 mo,
off-pump; 54.4  34.1 mo,
on-pump)
—
PS matching Median, 7.2 y (IQR, 7.0-7.4) —
ultivessel PS matching 10 y —
G PS matching Median, 5.9 y —
PS-adjusted CPHR 10 y —
PS matching Mean, 7.1 y; 362,254 pt-y —
Multivariable
Poisson regression
5.0  2.8 y (range, 0.5-10.5) —
myocardial infarction; EF, ejection fraction; CABG, coronary artery bypass grafting;
cal Management of Arterial Revascularization Therapies; CPHR, Cox proportional
opensity score; NY CSRS, New York State’s Cardiac Surgery Reporting System;
sed care in Heart Disease Evaluated According to Recommended Therapies; pt-y,
gery c November 2014
Takagi and Umemoto Acquired Cardiovascular Diseasewas still statistically significant. In general, exclusion of
any single study from the analysis did not substantively alter
the overall result of our analysis (Figure 2). Additionally,
pooling 10 PS-matched studiesE2,E4,E7-E9,E11-E14,E16
(56,028 patients) did not substantially change the pooled
estimate (fixed-effects HR, 1.05; 95% CI, 1.004 to 1.09;
P for overall effect ¼ .03; P for heterogeneity ¼ .51).Off-pump
Patients (n) Age (y) Women (%) DM (%)
100 62.2  9.6 18.0 19.0
100 63.8  8.5 18.0 32.0
200 63.0  9.1 18.0 25.5
149 62.2  10.0 18.8 29.5
155 61 22 29
142 61.7  9.2 33.8 9.2
98 62.5  9.5 22.4 32.7
733 — 28.1 —
8911 63.9  9.3 0.9 39.3
4970 63.7  11.2 28.8 33.2
1086 60.4  11.7 45.7 47.0
6056 63.1  11.4 31.9 35.7
862 63.9  9.5 16.5 23.5
732 64.9  10.8 31.4 33.2
2007 60.35  9.36 0 24.7
403 62.90  8.18 100 31.5
2410 60.78  9.22 16.7 25.9
250 66  9 22.0 41.6
346 66.5  10.6 20.8 50.0
2088 — — —
366 — — —
548 65.7  9.3 19.9 20.8
2631 67.7  11.0 29.8 31.6
307 62.3  11.8 28.7 35.2
308 63.5  10.6 25.3 27.6
540 82.9  2.8 45.9 28.0
2852 Mean, 65.4 26 18
947 64  10 27.0 17.8
TABLE 1. Continued
The Journal of Thoracic and CarPublication Bias
To assess the publication bias, we generated a funnel plot
of the logarithm of the effect size (HR) versus the precision
(reciprocal of the standard error) for each study (Figure 3).
No evidence was found of a significant publication bias
(2-tailed P ¼ .87 and P ¼ .55, adjusted rank correlation
and linear regression test, respectively).On-pump
Patient (n) Age (y) Women (%) DM (%)
100 61.7  8.6 21.0 14.0
101 61.2  9.2 14.9 29.7
201 61.4  8.9 17.9 21.9
150 63.7  10.0 20.0 36.0
153 59 20 27
139 60.8  8.8 29.5 16.5
99 62.2  11.1 23.2 33.3
778 — 25.1 —
26,733 63.9  8.9 1.0 40.1
5871 62.9  10.6 25.4 33.9
947 59.6  11.1 38.2 46.7
6818 62.4  10.7 27.2 35.7
862 64.2  9.1 17.9 23.5
7349 64.4  10.7 27.6 34.7
2460 59.61  7.69 0 23.4
489 60.74  6.94 100 32.9
2949 59.80  7.58 16.6 25.0
250 64  9 18.8 33.6
346 64.7  11.0 23.7 42.8
2088 — — —
8256 — — —
548 66.2  8.7 19.2 20.6
2631 67.7  10.7 29.3 30.9
307 62.6  7.9 31.3 32.2
308 62.7  10.6 27.3 26.6
397 82.3  2.4 44.6 27.2
2852 Mean, 66.1 25 20
8461 66  9 21.1 20.4
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TABLE 2. Details of revascularization
Study Subgroup
Graft/patient (n) Index of completeness of revascularization
Off-pump On-pump P value Off-pump On-pump P value
Randomized controlled trial
Angelini (BHACAS 1
and 2),20 2009
BHACAS 1* Median, 2 (range, 1-4) Median, 2
(range, 1–4)
.3 — — —
BHACAS 1
and 2y
3 grafts in patients
of 45.0%
3 grafts in
patients of 56.2%
NS — — —
Karolak,21 2007 — Anastomosis; median,
2.8  0.9
Anastomosis;
median, 3.0  0.9
.06 — — —
Hueb (MASS III),15
2010
— 2.49 (anastomosis,
2.60)
2.97 (anastomosis,
3.18)
<.001 — — —
van Dijk (Octopus),2
2007
— Anastomosis; median,
2.4  1.0z
Anastomosis;
median, 2.6  1.0z
.05 — — —
Puskas (SMART),24
2011
— 3.39 3.40 — 1.01 1.00 —
Adjusted observational study
Brown,E1 2008 — 3.0 3.3 <.001 — — —
Bakaeen (CICSP),E2
2013
— 2.66  1.03 (3
anastomoses in
patients of 56.3%)
3.18  0.89 (3
anastomoses in
patients, 79.5%)
<.0001 — — —
Cooper,E3 2009 — — — — — — —
Di Mauro,E4 2007 — Anastomosis; median,
2.6  0.7
Anastomosis;
median, 2.6  0.7
.717 — — —
Filardo,E5 2011 — — — — — — —
Fu,E6 2009 Men Saphenous and arterial
anastomoses,
1.90  0.96 and
1.09  0.52,
respectively
Saphenous and
arterial
anastomoses,
2.75  1.01 and
1.07  0.50,
respectively
— 1.1108  0.3188 1.3556  0.3265 <.0001
Women Saphenous and arterial
anastomoses,
1.90  0.95 and
0.95  0.41,
respectively
Saphenous and
arterial
anastomoses,
2.70  0.95 and
0.94  0.44,
respectively
— 1.0544  0.2813 1.2962  0.3564 <.0001
Garcıa Fuster,E7 2013 — 2.7  1.0 2.8  0.9 .35 — — —
Gorki,E8 2010 — 3.10  0.88 3.53  1.02 — — — —
Hu,E9 2010 — — — — 1.1  0.3 (complete
in patients, 87.2%)x
1.3  0.3
(complete
in patients,
96.0%)x
<.001
Locker,E10 2013 — — — — — — —
Murzi,E11 2012 — 2.7  0.7 3  0.7 .001 1  0.3 (complete
in patients, 88.3%)
1.1  0.3
(complete
in patients,
92.0%)
.001 (.04)
Wu (NY CSRS),E12
2012
— Anastomosis; median,
2.69x
Anastomosis;
median, 3.34x
<.001 — — —
Raja,E13 2013 — 2.91  1.06x 3.4  0.4x <.01 1.09  0.17x 1.11  0.19x .87
Robertson,E14 2013 — 3 Anastomoses in
patients, 51.9%
3 Anastomoses in
patients, 68.5%
.0001 Complete in patients,
79.2%
Complete in
patients, 88.3%
.002
Sarin,E15 2011 — — — — — — —
Dalen
(SWEDEHEART),E16
2013
— 2.0  1.0x 3.5  1.0x <.001 — — —
(Continued)
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TABLE 2. Continued
Study Subgroup
Graft/patient (n) Index of completeness of revascularization
Off-pump On-pump P value Off-pump On-pump P value
Synnergren,E17 2008 — — — — Complete in
patients, 67.1%
Complete in
patients, 82.9%
<.001
BHACAS, Beating Heart Against Cardioplegic Arrest Studies; NS, not significant; MASS, Medicine, Angioplasty, or Surgery Study; SMART, Surgical Management of Arterial
Revascularization Therapies; CICSP, Continuous Improvement in Cardiac Surgery Program; NY CSRS, New York State’s Cardiac Surgery Reporting System; SWEDEHEART,
Swedish Web-system for Enhancement and Development of Evidence-based care in Heart Disease Evaluated According to Recommended Therapies. *Data from Ascione R,
Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized
study. Circulation. 2000;102:1530-5. yData from Angelini et al.3 zData from van Dijk D, Nierich AP, Jansen EW, Nathoe HM, Suyker WJ, Diephuis JC, et al, Octopus Study
Group. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation. 2001;104:1761-6. xUnmatched patients.
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DDISCUSSION
The results of our analysis suggest that off-pump CABG
might be associated with worse long-term (5-year)
survival compared with on-pump CABG. The results from
the adjusted observational studies were the most
compelling, with data from 102,820 patients in 17 different
studies demonstrating a 7% increase in all-cause mortality
with off-pump relative to one-pump CABG that was robustTABLE 3. Graft patency and cardiac events
Outcome Study
Graft patency
BHACAS 1 and 2,20 2009
SMART,24 2011
Cardiac mortality
Octopus,2 2007
Hu,E9 2010
Repeat revascularization
BHACAS 1 and 2,20 2009
MASS III,15 2010
Octopus,2 2007
SMART,24 2011
Hu,E9 2010
Raja,E13 2013
Angina
BHACAS 1 and 2,20 2009
MASS III,15 2010
SMART,24 2011
Hu,E9 2010
Myocardial infarction
BHACAS 1 and 2,20 2009
MASS III,15 2010
Octopus,2 2007
Hu,E9 2010
Rehospitalization for cardiac reason
Karolak,21 2007
Hu,E9 2010
Raja,E13 2013
Robertson,E14 2013
SWEDEHEART,E16 2013
BHACAS, Beating Heart Against Cardioplegic Arrest Studies; SMART, Surgical Manageme
Study; SWEDEHEART, Swedish Web-system for Enhancement and Development of Evid
*Patency rate. yRandomized patients. zPer 1000 person-years. xPropensity-score matche
infarction. **Composite of all-cause mortality and rehospitalization for myocardial infarc
The Journal of Thoracic and Carin the sensitivity analyses, even after eliminating the highest
weight and largest size,E2 second highest weight,E12 or sec-
ond largest size study.E3 The data from 5 randomized
controlled trials were less robust, however, likely owing
to the systematic underpowering of these trials in the
design phase and, primarily, the small number of
enrolled patients (n ¼ 1486). The observed 14% increase
(underpowered as reflected by the wide 95% CIs andEvent rate (%)
Off-pump On-pump P value
89.0*,y 89.4*,y >.99
76*,y 83.5*,y .44
0y 1.4y .24
5.9z,x 6.1z,x .54
1.5y 1.5y 1.00jj
6.5y 5.9y .84
7.7y 5.0y .47
2.3y 2.3y 1.0
9.1z,x 8.4z,x .03
0.7x 0.7x 1.00
14.0y 18.9y .19jj
11.8y 6.7y .09
25.6y 11.4y .09
28.7z,x 24.7z,x .002
4.0y 4.0y .99jj
6.5y,{ 2.0y,{ .05
4.9y 6.5y .62
3.3z,x,# 2.8z,x,# .22
35y 35y .57
45.2z,x 37.5z,x <.001
3.3x 3.6x .93
31.7x 31.9x .72
51x,** 57x,** .22
nt of Arterial Revascularization Therapies;MASS, Medicine, Angioplasty, or Surgery
ence-based care in Heart Disease Evaluated According to Recommended Therapies.
d patients. jjCalculated by us. {Acute myocardial infarction. #Nonfatal myocardial
tion, heart failure, or stroke.
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FIGURE 1. Forest plot of hazard ratios for long-term all-cause mortality among patients assigned to off-pump versus on-pump coronary artery bypass
grafting. SE, Standard error; IV, inverse variance; CI, confidence interval; BHACAS, Beating Heart Against Cardioplegic Arrest Studies;MASS, Medicine,
Angioplasty, or Surgery Study; SMART, Surgical Management of Arterial Revascularization Therapies; CICSP, Continuous Improvement in Cardiac
Surgery Program; NY CSRS, New York State’s Cardiac Surgery Reporting System; SWEDEHEART, Swedish Web-system for Enhancement and
Development of Evidence-based care in Heart Disease Evaluated According to Recommended Therapies.
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the patients undergoing off-pump CABG is far lower
than the 34% increase in >30-day mortality (risk ratio
[RR], 1.34; 95% CI, 1.08-1.67; P ¼ .009) and 35%
increase in 1-year mortality (odds ratio, 1.35; 95% CI,
1.07-1.70; P ¼ .01) demonstrated in the recent Cochrane
systematic review1 and our previous meta-analysis,19
respectively.
In off-pump versus on-pump CABG, the best evidence of
a lower number of distal anastomoses1 and the rate of graft
patency25 could explain the worse long-term survival
demonstrated in the present meta-analysis. This is because
CABG with complete revascularization improves survival
compared with CABG with incomplete revascularization
in patients with multivessel disease.26 The average mean
difference in the number of distal anastomoses after
off-pump CABG was 0.28 (95% CI, 0.40 to 0.16;
P< .00001) in the Cochrane meta-analysis1 of 57 trials
(7071 participants). A recent 2014 meta-analysis by Zhang
and colleagues25 of 12 randomized controlled trials (38941826 The Journal of Thoracic and Cardiovascular Surand 4137 grafts performed during off-pump CABG and
on-pump CABG, respectively) showed an increased risk
of occlusion of all grafts (RR, 1.35; 95% CI, 1.16-1.57;
P< .001) and saphenous vein grafts (RR, 1.41; 95% CI,
1.24-1.60; P< .001) in the off-pump group. However, no
significant difference was found in graft occlusion of the
left internal mammary artery (RR, 1.15; 95% CI,
0.83-1.59; P ¼ .407) or radial artery (RR, 1.37; 95% CI,
0.76-2.47; P ¼ .298) grafts between off pump and on-
pump CABG. However, our recent 2014 meta-analysis26
of adjusted HRs (not unadjusted) from 14 observational
studies (30,389 patients) demonstrated a statistically
significant 37% reduction in follow-up mortality with
complete revascularization relative to incomplete revascu-
larization (HR, 0.63; 95% CI, 0.53-0.75; P < .00001).
Furthermore, the finding of worse long-term survival after
off-pump relative to on-pump CABGmight be strengthened
by the results from another 2013 meta-analysis.27 The
pooled analysis of 12 randomized trials enrolling a total
of 11,594 patients demonstrated a statistically significantgery c November 2014
FIGURE 2. One-study-removed meta-analysis of hazard ratios for all-cause long-term mortality among patients assigned to off-pump versus on-pump
coronary artery bypass grafting. CI, Confidence interval; BHACAS, Beating Heart Against Cardioplegic Arrest Studies; MASS, Medicine, Angioplasty,
or Surgery Study; SMART, Surgical Management of Arterial Revascularization Therapies; CICSP, Continuous Improvement in Cardiac Surgery Program;
NY CSRS, New York State’s Cardiac Surgery Reporting System; SWEDEHEART, Swedish Web-system for Enhancement and Development of
Evidence-based care in Heart Disease Evaluated According to Recommended Therapies.
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off-pump relative to on-pump CABG (odds ratio, 1.38;
95% CI, 1.09-1.76; P ¼ .008).27
Successful performance of off-pump CABG seems likely
to depend on initial technical risks more than with on-pump
CABG, because, inherently, on a beating heart, performing
delicate anastomoses is difficult and the potential degree of
revascularization completeness or quality low.28 Thus, to
guarantee surgeon’ skill in the assigned technique
(off-pump or on-pump CABG), the approach of an
expertise-based randomized controlled trial29 should be
used. In the largest size (4752 patients) randomized
controlled trial, the CABG Off or On Pump Revasculariza-
tion Study,28 expertise was defined as >2 years of
experience and the completion of >100 procedures
involving the specific technique. Those surgeons who had
met these criteria for each type of operation separately
were considered to have expertise in both techniques and
were allowed to perform both types of CABG during the
trial.28 The investigators of the trial30 found, at 1 year, no
significant differences between the 2 groups in the rate of
death (HR, 0.87; 95% CI, 0.58-1.31), nonfatal stroke,
nonfatal myocardial infarction, or nonfatal new renal
failure requiring dialysis or in the rate of subsequent
revascularization procedures. Also, in the second largestThe Journal of Thoracic and Carsize (2370 patients) randomized trial, German Off-Pump
Coronary Artery Bypass Grafting in Elderly Patients,31
the study surgeons were required to be established experts
in the performance of either off-pump or on-pump CABG
and the average number of CABG surgeries performed
before the study was 514 off-pump (median, 322) for the
off-pump CABG surgeons and 1378 on-pump (median,
578) for the on-pump CABG surgeons. The trial
showed no significant differences between off-pump and
on-pump CABG with regard to death (HR, 0.88; 95% CI,
0.65-1.18; P ¼ .38), stroke, myocardial infarction, repeat
revascularization, or new renal replacement therapy within
12 months after surgery.31 The mid-term and long-term
outcomes of these large-size expertise-based randomized
trials are expected.
Our analysis must be viewed in the context of its
limitations. First, we used data from adjusted observational
studies and randomized controlled trials. Although the
study design of the randomized trials, which balance both
known and unknown confounders across treatment groups,
is the least vulnerable to bias, the patients enrolled in them
might not be representative of the patients typically seen in
clinical practice. However, because the potential biases
must be greater for observational studies than for the
randomized trials, the results should be always interpreteddiovascular Surgery c Volume 148, Number 5 1827
FIGURE 3. Funnel plot of the logarithm of effect size (hazard ratio)
versus the precision (reciprocal of the standard error [Std Err]) for each
study.
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analyses.32 Particular concerns arise in terms of differences
between patients in different intervention groups (selection
bias). In contrast to randomized trials, it would usually be
appropriate to analyze adjusted (ie, attempting to control
for confounding), rather than unadjusted, effect estimates.32
To reduce the effect of treatment-selection bias and
potential confounding in observational studies, rigorous
adjustment for significant differences in the baseline
characteristics of the patients should be conducted.
Furthermore, adjusted estimates (not unadjusted) should
be pooled in a meta-analysis that includes observational
studies. In the present meta-analysis, we strictly abstracted
(and then combined in a meta-analysis) exclusive adjusted
relative risk estimates (not unadjusted) from the
observational studies. Second, our results could have been
influenced by a publication bias favoring on-pump
CABG. This risk was minimized through an exhaustive
search of the available published data. Although the
statistical test results did not indicate a publication bias,
we clearly had limited power to detect such a bias, given
the small number of studies examined.
CONCLUSIONS
We found that, from a meta-analysis of 22 studies
enrolling a total of>100,000 patients, off-pump CABG is
likely to be associated with worse long-term (5-year) sur-
vival compared with on-pump CABG. Because a long-term
mortality reduction must imply the greatest clinical benefit
among patients undergoing CABG, on-pump rather than
off-pump CABG should be considered for patients without
contraindications to cardiopulmonary bypass. The long-
term results of large (>2000 patients) randomized1828 The Journal of Thoracic and Cardiovascular Surcontrolled trials, such as the CABG Off or On Pump
Revascularization Study,30 German Off-Pump Coronary
Artery Bypass Grafting in Elderly Patients,31 and
Randomized On/Off Bypass14 study, will render the last
judgment for the question of whether to pump or not to
pump.References
1. Møller CH, Penninga L, Wetterslev J, Steinbr€uchel DA, Gluud C. Off-pump
versus on-pump coronary artery bypass grafting for ischaemic heart disease.
Cochrane Database Syst Rev 2012;CD007224.
2. van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EW, et al; Octopus
Study Group. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump
coronary artery bypass graft surgery. JAMA. 2007;297:701-8.
3. Angelini GD, Taylor FC, Reeves BC, Ascione R. Early and midterm outcome
after off-pump and on-pump surgery in Beating Heart Against Cardioplegic
Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised
controlled trials. Lancet. 2002;359:1194-9.
4. Muneretto C, Bisleri G, Negri A, Manfredi J, Metra M, Nodari S, et al. Off-pump
coronary artery bypass surgery technique for total arterial myocardial
revascularization: a prospective randomized study. Ann Thorac Surg. 2003;76:
778-82; discussion 783.
5. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, et al.
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft
patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004;291:
1841-9.
6. Lee JD, Lee SJ, Tsushima WT, Yamauchi H, Lau WT, Popper J, et al. Benefits of
off-pump bypass on neurologic and clinical morbidity: a prospective randomized
trial. Ann Thorac Surg. 2003;76:18-25; discussion 25-6.
7. Karolak W, Hirsch G, Buth K, Legare JF. Medium-term outcomes of coronary
artery bypass graft surgery on pump versus off pump: results from a randomized
controlled trial. Circulation. 2006;114(18 Suppl):363.
8. Widimsky P, Straka Z, Stros P, Jirasek K, Dvorak J, Votava J, et al. One-year
coronary bypass graft patency: a randomized comparison between off-pump
and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation.
2004;110:3418-23.
9. Lingaas PS, Hol PK, Lundblad R, Rein KA, Mathisen L, Smith HJ, et al. Clinical
and radiologic outcome of off-pump coronary surgery at 12 months follow-up: a
prospective randomized trial. Ann Thorac Surg. 2006;81:2089-95.
10. Al-Ruzzeh S, George S, Bustami M, Wray J, Ilsley C, Athanasiou T, et al. Effect
of off-pump coronary artery bypass surgery on clinical, angiographic,
neurocognitive, and quality of life outcomes: randomised controlled trial.
BMJ. 2006;332:1365.
11. Motallebzadeh R, Bland JM, Markus HS, Kaski JC, Jahangiri M. Health-
related quality of life outcome after on-pump versus off-pump coronary artery
bypass graft surgery: a prospective randomized study. Ann Thorac Surg. 2006;
82:615-9.
12. Mazzei V, Nasso G, Salamone G, Castorino F, Tommasini A, Anselmi A.
Prospective randomized comparison of coronary bypass grafting with minimal
extracorporeal circulation system (MECC) versus off-pump coronary surgery.
Circulation. 2007;116:1761-7.
13. Hernandez F Jr, Brown JR, Likosky DS, Clough RA, Hess AL, Roth RM, et al.
Neurocognitive outcomes of off-pump versus on-pump coronary artery bypass: a
prospective randomized controlled trial. Ann Thorac Surg. 2007;84:1897-903.
14. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, et al;
Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group. On-pump
versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361:
1827-37.
15. Hueb W, Lopes NH, Pereira AC, Hueb AC, Soares PR, Favarato D, et al.
Five-year follow-up of a randomized comparison between off-pump and
on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial.
Circulation. 2010;122(11 Suppl):S48-52.
16. Fattouch K, Guccione F, Dioguardi P, Sampognaro R, Corrado E, CarusoM, et al.
Off-pump versus on-pump myocardial revascularization in patients with
ST-segment elevation myocardial infarction: a randomized trial. J Thorac
Cardiovasc Surg. 2009;137:650-6; discussion 656-7.
17. Sousa Uva M, Cavaco S, Oliveira AG, Matias F, Silva C, Mesquita A, et al.
Early graft patency after off-pump and on-pump coronary bypass surgery:
a prospective randomized study. Eur Heart J. 2010;31:2492-9.gery c November 2014
Takagi and Umemoto Acquired Cardiovascular Disease
A
C
D18. Møller CH, Perko MJ, Lund JT, Andersen LW, Kelbæk H, Madsen JK, et al.
Three-year follow-up in a subset of high-risk patients randomly assigned to
off-pump versus on-pump coronary artery bypass surgery: the Best Bypass
Surgery trial. Heart. 2011;97:907-13.
19. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T. Ask not which can
impair early morbidity—ask which can improve late survival: a meta-analysis
of randomized trials of off-pump versus on-pump coronary artery bypass.
Int J Cardiol. 2012;158:435-8.
20. Angelini GD, Culliford L, Smith DK, Hamilton MC, Murphy GJ, Ascione R,
et al. Effects of on- and off-pump coronary artery surgery on graft patency, sur-
vival, and health-related quality of life: long-term follow-up of 2 randomized
controlled trials. J Thorac Cardiovasc Surg. 2009;137:295-303.
21. Karolak W, Hirsch G, Buth K, Legare JF. Medium-term outcomes of coronary
artery bypass graft surgery on pump versus off pump: results from a randomized
controlled trial. Am Heart J. 2007;153:689-95.
22. Michaux I, Filipovic M, Skarvan K, Bolliger D, Schumann R, Bernet F, et al. A
randomized comparison of right ventricular function after on-pump versus
off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg.
2011;141:361-7.
23. Serrano CV Jr, Souza JA, Lopes NH, Fernandes JL, Nicolau JC, Blotta MH, et al.
Reduced expression of systemic proinflammatory and myocardial biomarkers
after off-pump versus on-pump coronary artery bypass surgery: a prospective
randomized study. J Crit Care. 2010;25:305-12.
24. Puskas JD, Williams WH, O’Donnell R, Patterson RE, Sigman SR, Smith AS,
et al. Off-pump and on-pump coronary artery bypass grafting are associated
with similar graft patency, myocardial ischemia, and freedom from
reintervention: long-term follow-up of a randomized trial. Ann Thorac Surg.
2011;91:1836-42; discussion 1842-3.EDITORIAL CO
See related article on pages 1820-9.
From the Division of Cardiac Surgery, Boston Medical Center, Boston, Mass.
Disclosures: Author has nothing to disclose with regard to commercial support.
Address for reprints: Harold L. Lazar, MD, Division of Cardiac Surgery, BostonMed-
ical Center, 88 E Newton St, Boston, MA 02118 (E-mail: harold.lazar@bmc.org).
J Thorac Cardiovasc Surg 2014;148:1829-31
0022-5223/$36.00
Copyright  2014 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2014.10.002
The Journal of Thoracic and Car25. Zhang B, Zhou J, Li H, Liu Z, Chen A, Zhao Q. Comparison of graft patency
between off-pump and on-pump coronary artery bypass grafting: an updated
meta-analysis. Ann Thorac Surg. 2014;97:1335-41.
26. Takagi H, Watanabe T, Mizuno Y, Kawai N, Umemoto T. ALICE (All-Literature
Investigation of Cardiovascular Evidence) Group. A meta-analysis of adjusted
risk estimates for survival from observational studies of complete versus
incomplete revascularization in patients with multivessel disease undergoing cor-
onary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2014;18:679-82.
27. Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T. ALICE (All-Literature
Investigation of Cardiovascular Evidence) Group. A meta-analysis of
randomized trials for repeat revascularization following off-pump versus
on-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg.
2013;17:878-80.
28. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al;
CORONARY Investigators. Off-pump or on-pump coronary-artery bypass graft-
ing at 30 days. N Engl J Med. 2012;366:1489-97.
29. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, et al.
Need for expertise based randomised controlled trials. BMJ. 2005;330:88.
30. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al;
CORONARY Investigators. Effects of off-pump and on-pump coronary-artery
bypass grafting at 1 year. N Engl J Med. 2013;368:1179-88.
31. Diegeler A, B€orgermann J, Kappert U, Breuer M, B€oning A, Ursulescu A, et al;
GOPCABE Study Group. Off-pump versus on-pump coronary-artery bypass
grafting in elderly patients. N Engl J Med. 2013;368:1189-98.
32. Reeves BC, Deeks JJ, Higgins JP, Wells GA. Including non-randomized studies.
In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration,
2011. Available at: http://www.cochrane-handbook.org. Accessed May 5, 2014.MMENTARYShould off-pump coronary artery bypass surgery be abandoned?
A potential solutionHarold L. Lazar, MDIn this issue of the Journal, in a meta-analysis of 22 studies
enrolling more than 100,000 patients, Takagi
and coworkers1 conclude that coronary artery bypass
grafting surgery (CABG) performed off-pump (OPCAB)
is associated with worse long-term (>5 years) survival
than on-pump CABG (ONCAB).1 The number of grafts
performed per patient and the index of completeness ofrevascularization were significantly greater for ONCAB
than OPCAB patients. Furthermore, the need for repeat
revascularization, recurrent angina, and rehospitalization
for cardiac-related issues were also more frequent in the
OPCAB group.
Previous studies have shown a 37% reduction in late mor-
tality in patients undergoingCABGwhohavehad a complete
versus an incomplete revascularization.2 Several studies
have reported a higher incidence of incomplete revasculari-
zation with OPCAB techniques, and this has been proposed
as a mechanism for the decreased long-term survival in these
patients.2-7 OPCAB has also been associated with decreased
graft patency, which may be responsible for decreased long-
term survival and an increased need for repeated revascular-
ization procedures.8 The results of the study by Takagi and
coworkers1 are similar to a recent Cochrane pooled analysis
of data from more than 80 trials of ONCAB versus OPCAB
that shows superior short-term andmidterm survival with the
ONCAB technique.9diovascular Surgery c Volume 148, Number 5 1829
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